Tyme Technologies

$1.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-1.94%) Today
+$0.01 (+0.98%) As of 7:00 AM EST after-hours

Why Robinhood?

You can buy or sell TYME and other stocks, options, and ETFs commission-free!

About TYME

Tyme Technologies, Inc. Common Stock, also called Tyme Technologies, is a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. The listed name for TYME is Tyme Technologies, Inc. Common Stock.

CEO
Steve Hoffman
Employees
18
Headquarters
Bedminster, New Jersey
Founded
2011
Market Cap
131.47M
Price-Earnings Ratio
Dividend Yield
Average Volume
342.55K
High Today
$1.04
Low Today
$1.01
Open Price
$1.04
Volume
180.80K
52 Week High
$2.04
52 Week Low
$0.85

Collections

TYME Earnings

-$0.07
-$0.05
-$0.02
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
per share
Actual
Expected Mar 24, Pre-Market

You May Also Like